REVIEW 4 major objections 6 minor 34 references
Clinical RAG systems can pass every standard accuracy check while attributing one drug’s real trial evidence to a completely different queried drug.
Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →
T0 review · grok-4.5
2026-07-13 03:40 UTC pith:YAA6NTHW
load-bearing objection Real, evaluation-invisible entity-attribution failure in clinical RAG, with solid multi-method support; the 98.7% EAV recall is thinner than the headline suggests. the 4 major comments →
Deceptive Grounding: Entity Attribution Failure in Clinical Retrieval-Augmented Generation
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
Core claim
A clinical RAG response can pass hallucination detection, faithfulness scoring, and citation verification while presenting drug Y’s real clinical evidence as evidence about the queried drug X. This deceptive grounding is evaluation-invisible by design. Under peak adversarial retrieval, rates span 8–87% across thirteen models (medical and biomedical models up to 86.7%); production measurement finds 7.8% overall and 13.6% for recently approved drugs. Entity-attribution verification detects it at 97.0% precision and 98.7% DG recall on an IPW-adjusted human gold standard.
What carries the argument
Deceptive grounding (DG): faithful relay of retrieved evidence attributed to the wrong entity. The carrying mechanism is a two-stage permission gate—Stage 1 opens via shared disease context or document framing; Stage 2 routes to entity-attribution failure when completing clinical details (trial names, NCT numbers, outcomes) are present in the wrong-entity documents, or to confabulation when they are removed. Completing-information ablation eliminates entity-attribution failure entirely while total incorrect responses remain high.
Load-bearing premise
The full-scale rates and the 98.7% recall claim rest on an automated judge whose calibration was checked on a modest human sample after the same model also wrote the synthetic documents used in the benchmark.
What would settle it
Re-adjudicate a large random sample of the full factorial responses with independent human experts; if the discontinuous jump at completing information, the drop of entity-attribution failure to 0% under ablation, or the production 7.8% rate disappear under that re-labeling, the central claims fail.
If this is right
- Clinical RAG benchmarks must add entity-attribution verification; faithfulness and citation metrics are structurally blind to this failure.
- Prioritizing entity-specific retrieval for the queried drug is the highest-leverage single intervention, suppressing DG to at most 6.4% in the controlled conditions.
- Medical and biomedical fine-tuning amplify rather than reduce risk, so training must enforce entity-identity constraints before evidence synthesis.
- Recently approved drugs carry elevated risk (13.6%) because entity-specific retrieval is sparsest.
- A complete detector needs both entity-attribution verification (for DG) and an NER-based check (for pure entity substitution).
Where Pith is reading between the lines
- The same silent misattribution pattern is likely wherever RAG retrieves near-neighbor entities in a dense space—companies, statutes, chemical compounds, or historical figures—not only drugs.
- Regulatory checklists for AI medical devices that omit entity-attribution accuracy leave a safety gap already measurable in production systems.
- Instruction-based anchoring helps models whose Stage 1 is driven by parametric priors but does little for models that open Stage 1 via document framing, pointing to architecture-specific fixes.
- The large gap between adversarial and naturalistic rates implies the practical monitoring target is retrieval pipelines that accidentally surface highly completing documents about the wrong entity.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The paper defines deceptive grounding (DG): a clinical RAG failure in which a model faithfully relays real evidence about alternate entity Y as evidence about queried entity X, thereby passing standard hallucination, faithfulness, and citation checks. Using a 2D factorial retrieval benchmark over 264 drug–disease–alternate triples and 13 models, the authors report peak adversarial DG rates of 8–87% (medical/biomedical models up to 86.7%), a two-stage mechanism supported by a completing-information ablation (entity-attribution failure 67%→0% with failures shifting to confabulation), label-substitution and noticing experiments, and entity-attribution verification (EAV) at 97.0% precision / 98.7% DG recall on an IPW-adjusted human gold standard (n=88). Production measurement on 740 drug–disease pairs finds 7.8% overall DG (13.6% for recently approved drugs).
Significance. If the core results hold, the paper identifies a clinically material, evaluation-invisible failure mode that existing RAG safety frameworks are structurally unable to catch. Strengths include a clean formal definition and three-tier taxonomy; a controlled factorial design with a load-bearing single-variable CIT ablation; multi-model scale (13 models) with profile taxonomy; human adjudication that independently confirms directional findings R1–R4; and a pre-registered production measurement with negative controls. The work is directly actionable for clinical RAG evaluation (add entity-attribution checks) and retrieval design (prioritize entity-specific evidence). These contributions are substantial for clinical NLP and RAG safety even if absolute detection metrics require tempering.
major comments (4)
- [§5.4 / Abstract / Contribution 3] §5.4, Abstract, and Contribution 3: The headline EAV claim of 98.7% DG/EAF recall rests on an IPW-adjusted human gold standard with neff≈18 EAF-positive cases (n=88 adjudicated; CI [82.4, 100.0]). That interval is compatible with materially lower true recall and does not securely distinguish a near-perfect detector from a useful but incomplete one. Precision (97.0% [87.7, 99.0]) and 0.0% FPR on clean controls are better supported. Either expand independent human adjudication of EAF-positive cases to a sample that can underwrite a tight recall claim, or reframe Contribution 3 / the abstract to lead with precision, specificity, and complementarity to NER-based ES detection rather than near-perfect recall.
- [§4 / Appendix B / Tables 1–2] §4 and Appendix B: Kimi-K2.5 both generates the synthetic Cy documents that embed CITs and serves as the primary full-scale judge. Human adjudication and a second-model judge break circularity for directional conclusions R1–R4, but full-scale absolute DG rates in Tables 1–2 remain Kimi-judged. The dual role should be treated as a calibration risk for absolute rates: report full-scale rates under the second judge (or a larger human-adjudicated subsample stratified by condition) as a sensitivity analysis, and state clearly in the main text which claims are judge-invariant versus Kimi-dependent.
- [Table 2 / §5.2 / Abstract] Table 2 and §5.2: Absolute peak DG% for non-L1 models are lower bounds because CITs were elicited from L1-16B-A3B’s pharmacological prior (Appendix C). This is acknowledged in the appendix and a table footnote, but the abstract and main-text cross-model claims (“8–87%”, “medical models reach up to 86.7%”) read as calibrated absolute rates. Promote the lower-bound framing into the abstract and the first paragraph of §5.2, and emphasize calibration-independent quantities (Cx protection ratios, gradient shapes, profile assignments, medical vs. general rank order) as the primary cross-model evidence.
- [§5.3 / Appendix D] §5.3 / Appendix D: The Stage-1 causal claim from activation patching is significant only for L1-16B-A3B (+13.7 pp vs. 0% random); Llama-3.1-70B is underpowered (near-floor baseline X-attribution). The two-stage gate is still well supported by the CIT ablation (Stage 2) and cross-model behavioral patterns, but the manuscript should not present pharmacological-class residual-stream patching as a general Stage-1 causal proof across architectures. Restrict the causal Stage-1 claim to L1 and treat class probing for other models as representational characterization.
minor comments (6)
- [§4 / Appendix B] Inter-rater κ=0.415 (Appendix B) is moderate; the complementary blind-spot analysis (Kimi ES definitional gap vs. Llama phrase-level EAF) is useful and should be summarized briefly in the main §4 measurement paragraph so readers do not treat κ alone as a red flag.
- [Table 3] Table 3: Make explicit in the table caption that EAV’s 0.0% ES recall is by design (no X-attributed claim to evaluate), so the “comprehensive system = EAV + NER” recommendation is not an afterthought.
- [§1 / Figure 1] Figure 1 and the rituximab/FOP example are clear; ensure NCT03188666 / garetosmab attribution is consistent wherever the example is reused so the pedagogical case cannot be misread as a factual error about the trial.
- [§5.5 / Abstract] Production §5.5: The 5.5× gap between worst-case naturalistic stratum (13.2%) and controlled absent×synthetic_Y (73.1%) is important; consider a short sentence in the abstract or conclusion so readers do not equate adversarial susceptibility with deployment prevalence.
- [§3 / Appendix E] Minor terminology: Tier-1 is variously called DG, EAF, and (in production pre-registration) entity_substitution; a single glossary mapping paper taxonomy to pre-registration labels would reduce confusion (Appendix E already notes the mismatch).
- [References] References include Gemma 4 and Kimi K2.5 with 2026 dates and some Hugging Face URLs; ensure citation completeness and stable identifiers for camera-ready.
Circularity Check
No load-bearing derivation circularity; only a partially mitigated measurement-loop risk (Kimi generates Cy docs and judges) that the paper itself flags and breaks for directional claims via human gold standard.
specific steps
-
other
[§4 Measurement; Appendix B 'Independence of Kimi document generation and judgment']
"We address potential circularity from using Kimi-K2.5 for both document generation and judgment in Appendix B; the human gold standard confirms all directional conclusions independently of Kimi calibration. ... Kimi-K2.5 generates synthetic Cy documents (temperature=0; structured factual writing task) and judges responses (entity-attribution reasoning task)."
Same model family writes the adversarial Cy documents (embedding CITs as Y’s evidence) and later scores whether subject-model responses misattribute that content to X. In principle this could couple document style to judge sensitivity. It is not self-definitional of DG rates (generation and judgment are different tasks; responses are from 13 other models), and human adjudication plus a second judge break the loop for R1–R4. Absolute full-scale rates still rest on Kimi alone—measurement contamination, not a prediction forced by construction.
full rationale
This is an empirical measurement paper, not a first-principles derivation. DG is defined structurally (Y-evidence presented as X, claims entailed by D), then rates, mechanism, and detection are measured—not deduced from the definition. The evaluation-invisibility claim is true by construction of that definition relative to faithfulness/hallucination/citation checks; that is the contribution (naming a blind spot), not a circular empirical result. Absolute DG rates are measurements under constructed stimuli, not fitted parameters renamed as predictions. CIT elicitation from L1’s prior is intentional stimulus design for studying that prior; ablation (67%→0% EAF when CITs removed), label-substitution, activation patching, production measurement (740 pairs), and human adjudication are independent of any self-fit. No uniqueness theorems, no self-citation load-bearing chain, no ansatz smuggled via overlapping authors. The only circularity-adjacent issue is dual use of Kimi-K2.5 for synthetic Cy document generation and EA V judgment—acknowledged in §4/Appendix B and partially broken by Llama inter-rater and n=88 human gold standard confirming R1–R4. That is measurement contamination risk, not a derivation that reduces to its inputs. Score 2 for that minor, non-load-bearing loop; central existence, mechanism, and production claims stand independently.
Axiom & Free-Parameter Ledger
free parameters (4)
- CIT inclusion threshold (≥3/8 samples)
- CIT elicitation temperature (0.7) and k=8 samples on L1-16B-A3B
- Human gold-standard sample size and IPW design (n=88 adjudicated, neff≈55)
- Activation-patching layer/token choices (e.g., L1 layer 13)
axioms (4)
- domain assumption Standard faithfulness/entailment metrics verify claim support by document content without requiring entity identity match between claim and document primary entity.
- ad hoc to paper A response is deceptive grounding iff claims from Y≠X documents are presented as evidence about X while remaining factually entailed by retrieved D.
- domain assumption LLM-as-judge labels (with human adjudication on a stratified subsample) are adequate primary metrics for large-scale DG rates.
- ad hoc to paper Completing Information Targets (trial names, NCT numbers, outcomes) mark the causal boundary between entity-attribution failure and confabulation under fixed Stage-1 conditions.
invented entities (4)
-
Deceptive grounding (DG / Tier-1 EAF)
independent evidence
-
Two-stage permission gate (Stage 1 context/prior; Stage 2 completing-info path)
no independent evidence
-
Entity-attribution verification (EAV)
independent evidence
-
Failure profiles P1–P6
no independent evidence
read the original abstract
Retrieval-augmented generation evaluation checks whether model claims are factually grounded in retrieved documents. It does not check whether retrieved evidence is attributed to the correct entity. A clinical RAG response can pass every automated check (zero hallucinations, near-perfect faithfulness, real citations) while presenting drug Y's clinical evidence as evidence about queried drug X. We term this deceptive grounding (DG): a failure invisible to faithfulness, hallucination, and citation checks because every claim is sourced from a real document, about the wrong entity. Using a controlled factorial benchmark across 13 models, we find DG rates spanning 8-87% at peak adversarial conditions. Medical and biomedical fine-tuned models reach up to 86.7%; domain specialization amplifies the failure rather than mitigating it. A controlled ablation identifies the mechanism: removing entity-specific clinical evidence from retrieved documents eliminates entity-attribution failure entirely, shifting all failures to confabulation. The two failure modes respond to the same trigger, taking different paths. Production measurement across 740 drug-disease pairs finds 7.8% overall DG in a deployed RAG system, rising to 13.6% for recently approved drugs. Entity-attribution verification (checking that cited evidence applies to the queried entity) detects DG at 97.0% precision and 98.7% DG recall (IPW-adjusted human gold standard); no existing framework implements it.
Figures
Reference graph
Works this paper leans on
-
[1]
Evaluation of Attribution Bias in Generator-Aware Retrieval-Augmented Large Language Models
Amin Abolghasemi, Leif Azzopardi, Seyyed Hadi Hashemi, Maarten de Rijke, and Suzan Verberne. Evaluation of attribution bias in generator-aware retrieval-augmented large language models. In Findings of the Association for Computational Linguistics: ACL 2025 , pages 21105--21124, Vienna, Austria, 2025. Association for Computational Linguistics. doi:10.18653...
work page internal anchor Pith review Pith/arXiv arXiv doi:10.18653/v1/2025.findings-acl.1087 2025
-
[2]
Self-RAG : Learning to retrieve, generate, and critique through self-reflection
Akari Asai, Zeqiu Wu, Yizhong Wang, Avirup Sil, and Hannaneh Hajishirzi. Self-RAG : Learning to retrieve, generate, and critique through self-reflection. In International Conference on Learning Representations (ICLR), 2024. arXiv:2310.11511
Pith/arXiv arXiv 2024
-
[3]
Cheng-Han Chiang and Hung-yi Lee. Merging facts, crafting fallacies: Evaluating the contradictory nature of aggregated factual claims in long-form generations. In Findings of the Association for Computational Linguistics: ACL 2024 , pages 2734--2751, Bangkok, Thailand, 2024. Association for Computational Linguistics. doi:10.18653/v1/2024.findings-acl.160....
-
[4]
Med42-v2 : A suite of clinical LLMs , 2024
Cl \'e ment Christophe, Praveen K Kanithi, Tathagata Raha, Shadab Khan, and Marco AF Pimentel. Med42-v2 : A suite of clinical LLMs , 2024
2024
-
[5]
Abhimanyu Dubey, Abhinav Jauhri, Abhinav Pandey, Abhishek Kadian, Ahmad Al-Dahle, et al. The Llama 3 herd of models. arXiv preprint arXiv:2407.21783, 2024
Pith/arXiv arXiv 2024
-
[6]
Nouha Dziri, Ehsan Kamalloo, Sivan Milton, Osmar Zaiane, Mo Yu, Edoardo M. Ponti, and Siva Reddy. FaithDial : A faithful benchmark for information-seeking dialogue. Transactions of the Association for Computational Linguistics, 10: 0 1473--1490, 2022. doi:10.1162/tacl_a_00529. arXiv:2204.10757
-
[7]
RAGAs : Automated evaluation of retrieval augmented generation
Shahul Es, Jithin James, Luis Espinosa-Anke, and Steven Schockaert. RAGAs : Automated evaluation of retrieval augmented generation. In Proceedings of the 18th Conference of the European Chapter of the Association for Computational Linguistics: System Demonstrations (EACL), 2024. arXiv:2309.15217
Pith/arXiv arXiv 2024
-
[8]
Language models are surprisingly fragile to drug names in biomedical benchmarks, 2024
Jack Gallifant, Shan Chen, Pedro Moreira, Nikolaj Munch, Mingye Gao, Jackson Pond, Leo Anthony Celi, Hugo Aerts, Thomas Hartvigsen, and Danielle Bitterman. Language models are surprisingly fragile to drug names in biomedical benchmarks, 2024. arXiv:2406.12066
Pith/arXiv arXiv 2024
-
[9]
RARR : Researching and revising what language models say, using language models
Luyu Gao, Zhuyun Dai, Panupong Pasupat, Anthony Chen, Arun Tejasvi Chaganty, Yicheng Fan, Vincent Zhao, Ni Lao, Hongrae Lee, Da-Cheng Juan, and Kelvin Guu. RARR : Researching and revising what language models say, using language models. In Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (ACL), pages 16477--16508, 20...
Pith/arXiv arXiv 2023
-
[10]
Gemma Team . Gemma 4. https://huggingface.co/google/gemma-4-27B-it, 2026 a
2026
-
[11]
Gemma Team . Gemma 4. https://huggingface.co/google/gemma-4-31B-it, 2026 b
2026
-
[12]
Lei Huang, Weijiang Yu, Weitao Ma, Weihong Zhong, Zhangyin Feng, Haotian Wang, Qianglong Chen, Weihua Peng, Xiaocheng Feng, Bing Qin, and Ting Liu. A survey on hallucination in large language models: Principles, taxonomy, challenges, and open questions. ACM Transactions on Information Systems, 43 0 (2): 0 1--55, 2025. doi:10.1145/3703155. arXiv:2311.05232
-
[13]
Survey of hallucination in natural language generation
Ziwei Ji, Nayeon Lee, Rita Frieske, Tiezheng Yu, Dan Su, Yan Xu, Etsuko Ishii, Ye Jin Bang, Andrea Madotto, and Pascale Fung. Survey of hallucination in natural language generation. ACM Computing Surveys, 55 0 (248), 2023. doi:10.1145/3571730. arXiv:2202.03629
-
[14]
WiCE : Real-world entailment for claims in wikipedia
Ryo Kamoi, Tanya Goyal, Juan Diego Rodriguez, and Greg Durrett. WiCE : Real-world entailment for claims in wikipedia. In Proceedings of the 2023 Conference on Empirical Methods in Natural Language Processing (EMNLP), 2023. arXiv:2303.01432
Pith/arXiv arXiv 2023
-
[15]
Kimi K2.5 : Visual agentic intelligence
Kimi Team . Kimi K2.5 : Visual agentic intelligence. arXiv preprint arXiv:2602.02276, 2026
Pith/arXiv arXiv 2026
-
[16]
Entity-based knowledge conflicts in question answering
Shayne Longpre, Kartik Perisetla, Anthony Chen, Nikhil Ramesh, Chris DuBois, and Sameer Singh. Entity-based knowledge conflicts in question answering. In Proceedings of the 2021 Conference on Empirical Methods in Natural Language Processing (EMNLP), 2021. arXiv:2109.05052
Pith/arXiv arXiv 2021
-
[17]
L1 : The first clinical language model by lunit
Lunit. L1 : The first clinical language model by lunit. https://huggingface.co/learning-unit/L1-16B-A3B, 2026
2026
-
[18]
Alex Mallen, Akari Asai, Victor Zhong, Rajarshi Das, Daniel Khashabi, and Hannaneh Hajishirzi. When not to trust language models: Investigating effectiveness of parametric and non-parametric memories. In Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (ACL), volume 1, 2023. arXiv:2212.10511
Pith/arXiv arXiv 2023
-
[19]
On faithfulness and factuality in abstractive summarization
Joshua Maynez, Shashi Narayan, Bernd Bohnet, and Ryan McDonald. On faithfulness and factuality in abstractive summarization. In Proceedings of the 58th Annual Meeting of the Association for Computational Linguistics (ACL), 2020. arXiv:2005.00661
Pith/arXiv arXiv 2020
-
[20]
FActScoring : Fine-grained atomic evaluation of factual precision in long-form text generation
Sewon Min, Kalpesh Krishna, Xinxi Lyu, Mike Lewis, Wen-tau Yih, Pang Wei Koh, Mohit Iyyer, Luke Zettlemoyer, and Hannaneh Hajishirzi. FActScoring : Fine-grained atomic evaluation of factual precision in long-form text generation. In Proceedings of the 2023 Conference on Empirical Methods in Natural Language Processing (EMNLP), 2023. arXiv:2305.14251
Pith/arXiv arXiv 2023
-
[21]
Capabilities of GPT-4 on medical challenge problems, 2023
Harsha Nori, Nicholas King, Scott Mayer McKinney, Dean Carignan, and Eric Horvitz. Capabilities of GPT-4 on medical challenge problems, 2023. arXiv:2303.13375
Pith/arXiv arXiv 2023
-
[22]
gpt-oss-120b & gpt-oss-20b model card, 2025
OpenAI . gpt-oss-120b & gpt-oss-20b model card, 2025
2025
-
[23]
OpenBioLLMs : Advancing open-source large language models for healthcare and life sciences
Ankit Pal and Malaikannan Sankarasubbu. OpenBioLLMs : Advancing open-source large language models for healthcare and life sciences. https://huggingface.co/aaditya/OpenBioLLM-Llama3-70B, 2024
2024
-
[24]
Qwen3.5 : Accelerating productivity with native multimodal agents
Qwen Team . Qwen3.5 : Accelerating productivity with native multimodal agents. https://huggingface.co/Qwen/Qwen3.5-122B-A10B, 2026
2026
-
[25]
ARES : An automated evaluation framework for retrieval-augmented generation systems
Jon Saad-Falcon, Omar Khattab, Christopher Potts, and Matei Zaharia. ARES : An automated evaluation framework for retrieval-augmented generation systems. In Proceedings of the 2024 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers), pages 338--354, Mexico City, Mex...
-
[26]
Large language models can be easily distracted by irrelevant context
Freda Shi, Xinyun Chen, Kanishka Misra, Nathan Scales, David Dohan, Ed Chi, Nathanael Sch \"a rli, and Denny Zhou. Large language models can be easily distracted by irrelevant context. In Proceedings of the 40th International Conference on Machine Learning (ICML), 2023. arXiv:2302.00093
Pith/arXiv arXiv 2023
-
[27]
Karan Singhal, Shekoofeh Azizi, Tao Tu, S. Sara Mahdavi, et al. Large language models encode clinical knowledge. Nature, 620: 0 172--180, 2023. doi:10.1038/s41586-023-06291-2
-
[28]
Groundedness in Retrieval-augmented Long-form Generation: An Empirical Study
Alessandro Stolfo. Groundedness in retrieval-augmented long-form generation: An empirical study. In Findings of the Association for Computational Linguistics: NAACL 2024 , pages 1537--1552, Mexico City, Mexico, 2024. Association for Computational Linguistics. doi:10.18653/v1/2024.findings-naacl.100. arXiv:2404.07060
work page internal anchor Pith review Pith/arXiv arXiv doi:10.18653/v1/2024.findings-naacl.100 2024
-
[29]
Food and Drug Administration
U.S. Food and Drug Administration . Artificial intelligence/machine learning ( AI/ML )-based software as a medical device ( SaMD ) action plan. Technical Report, January 2021
2021
-
[30]
Xiong, Shannon Zejiang Shen, Yoon Kim, and Monica Agrawal
Lionel Wong, Ayman Ali, Raymond M. Xiong, Shannon Zejiang Shen, Yoon Kim, and Monica Agrawal. Position: Retrieval-augmented systems can be dangerous medical communicators. In Proceedings of the 42nd International Conference on Machine Learning, Proceedings of Machine Learning Research, 2025. Position paper track. arXiv:2502.14898
Pith/arXiv arXiv 2025
-
[31]
Jian Xie, Kai Zhang, Jiangjie Chen, Renze Lou, and Yu Su. Adaptive chameleon or stubborn sloth: Revealing the behavior of large language models in knowledge conflicts. In International Conference on Learning Representations (ICLR), 2024. Spotlight. arXiv:2305.13300
Pith/arXiv arXiv 2024
-
[32]
Benchmarking retrieval-augmented generation for medicine
Guangzhi Xiong, Qiao Jin, Zhiyong Lu, and Aidong Zhang. Benchmarking retrieval-augmented generation for medicine. In Findings of the Association for Computational Linguistics: ACL 2024, 2024. arXiv:2402.13178
Pith/arXiv arXiv 2024
-
[33]
An Yang, Baosong Yang, Beichen Zhang, Binyuan Hui, Bo Zheng, Bowen Yu, Chengyuan Li, Dayiheng Liu, Fei Huang, Haoran Wei, et al. Qwen2.5 technical report. arXiv preprint arXiv:2412.15115, 2024
Pith/arXiv arXiv 2024
-
[34]
Cyril Zakka, Rohan Shad, Akash Chaurasia, Alex R. Dalal, et al. Almanac---retrieval-augmented language models for clinical medicine. NEJM AI, 1 0 (2), 2024. doi:10.1056/AIoa2300068
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.